Anuszewska E L, Gruber B M, Koziorowska J H
Drug Institute, Warsaw, Poland.
Biochem Pharmacol. 1997 Sep 1;54(5):597-603. doi: 10.1016/s0006-2952(97)00206-2.
Various investigations have reported the occurrence in bacterial and mammalian cells of an adaptive response to the toxic effects of oxidants or agents that cause oxidation via redox reactions. In our previous study, it was shown that several cell lines pretreated with a low dose of hydrogen peroxide (H2O2) exhibited an adaptive response to subsequent high doses of adriamycin (ADR), whereas other cell lines did not. Based on the observation that the cell lines utilized differed in their sensitivity towards adriamycin, we undertook the present investigation with the goal of evaluating possible relationships between the levels of antioxidant enzymes and sensitivity towards adriamycin. Another aim was to determine relationships between the inducibility of these enzymes and the occurrence of adaptation. We utilized African Green monkey kidney (V3), human embryo (CLV98), human melanoma (ME18), and Chinese hamster ovary (CHO) cell lines and experimentally developed adriamycin-resistant human melanoma (ME18/RN) and Chinese hamster ovary (CHO/RN) cell sublines. Cytotoxicity was measured by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay and trypan blue exclusion. The levels of catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx) were determined in the same kind of experiment as that revealing the occurrence of adaptation. The rank order established for catalase activities was similar to that for sensitivity towards adriamycin. Aberrant increases in the tested enzymes were demonstrated in experimental groups of all kinds of cells. We conclude that in our cell systems catalase is a major determinant of adriamycin resistance. Whether the occurrence of the adaptive response under study is dependent on the contribution of catalase, itself dependent on the degree of resistance to the drug, is discussed.
多项研究报告称,细菌和哺乳动物细胞会对氧化剂或通过氧化还原反应引起氧化的试剂的毒性作用产生适应性反应。在我们之前的研究中,发现用低剂量过氧化氢(H2O2)预处理的几种细胞系对随后的高剂量阿霉素(ADR)表现出适应性反应,而其他细胞系则没有。基于所使用的细胞系对阿霉素的敏感性不同这一观察结果,我们进行了本研究,目的是评估抗氧化酶水平与对阿霉素敏感性之间的可能关系。另一个目的是确定这些酶的诱导性与适应性发生之间的关系。我们使用了非洲绿猴肾(V3)、人胚胎(CLV98)、人黑色素瘤(ME18)和中国仓鼠卵巢(CHO)细胞系,并通过实验培育出了耐阿霉素的人黑色素瘤(ME18/RN)和中国仓鼠卵巢(CHO/RN)细胞亚系。通过MTT(3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐)法和台盼蓝排斥法测定细胞毒性。在揭示适应性发生的同类型实验中测定过氧化氢酶(CAT)、超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GPx)的水平。过氧化氢酶活性确定的排名顺序与对阿霉素的敏感性排名顺序相似。在所有类型细胞的实验组中均显示出受试酶的异常增加。我们得出结论,在我们的细胞系统中,过氧化氢酶是阿霉素耐药性的主要决定因素。本文还讨论了所研究的适应性反应的发生是否依赖于过氧化氢酶的作用,而过氧化氢酶本身又依赖于对药物的耐药程度。